Search
for
Sort by
Research 181–210 of 315
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- Dermatology and Pregnancy
- Dermatologia e Procedimentos Estéticos Ed. XVIII
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.
- Description of skin lesions
- Actualización del Síndrome de Ovario Poliquístico y su importancia en Dermatología
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Sterile matrix grafting for onycholysis in the setting of valproic acid use
- TACRINE
- Manejo de reações adversas dermatológicas em pacientes submetidos à terapia quimioterápica antineoplásica
- DIETHYLPROPION
- ZALCITABINE
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- A concomitant diagnosis of COVID‐19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- A rash diagnosis
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Dermatologic Manifestations of Systemic Diseases in Childhood
- ORLISTAT
- NEFAZODONE
- ESCITALOPRAM
- SARGRAMOSTIN
- QUINAPRIL
- Secondary Syphilis in Cali, Colombia: New Concepts in Disease Pathogenesis
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.